Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Bladder Cancer

Free Subscription 15.10.2018 1 Aging (Albany NY) 1 Anal Chim Acta 1 Analyst 2 Biomed Res Int 1 BJU Int 1 BMC Med Genomics 1 BMJ Case Rep 2 Cancer 1 Cancer Manag Res 1 Cancer Med 1 Cell Death Dis 1 Clin Genitourin Cancer 1 Clin Nucl Med 1 Clin Transl Oncol 1 Environ Mol Mutagen 1 Eur J Pharmacol 4 Eur Urol 1 Eur Urol Focus 1 Exp Oncol 1 Front Surg 2 In Vivo 1 Indian J Surg Oncol 1 Int J Hyperthermia 1 Int Neurourol J 1 J Cancer 1 J Cell Biochem 1 J Med Imaging Radiat Oncol 1 J Prev Med Public Health 1 J Proteomics 1 J Robot Surg 2 Mol Cancer 1 Mol Nutr Food Res 1 Molecules 1 Oncogene 1 Proc Natl Acad Sci U S A 1 Res Rep Urol 2 Sci Rep 1 Urologe A 1 World J Surg Oncol 4 World J Urol 1 Zhonghua Zhong Liu Za Zhi

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aging (Albany NY)

1. LIU H, Chen D, Bi J, Han J, et al
   Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.
   Aging (Albany NY). 2018 Oct 12. pii: 101573. doi: 10.18632/aging.101573.
   PubMed     Text format     Abstract available
   
   

   
   Anal Chim Acta

2. YUMBA MPANGA A, Siluk D, Jacyna J, Szerkus O, et al
   Targeted metabolomics in bladder cancer: From analytical methods development and validation towards application to clinical samples.
   Anal Chim Acta. 2018;1037:188-199.
   PubMed     Text format     Abstract available
   
   

   
   Analyst

3. PHADKE GS, Satterwhite-Warden JE, Choudhary D, Taylor JA, et al
   A novel and accurate microfluidic assay of CD62L in bladder cancer serum samples.
   Analyst. 2018 Oct 8. doi: 10.1039/c8an01463.
   PubMed     Text format     Abstract available
   
   

   
   Biomed Res Int

4. ZENG X, Huang H, Li J, Peng J, et al
   The Clinical and Radiological Characteristics of Inflammatory Myofibroblastic Tumor Occurring at Unusual Sites.
   Biomed Res Int. 2018;2018:5679634.
   PubMed     Text format     Abstract available
   
   
5. WANG H, Gao L, Meng C, Yu N, et al
   Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors.
   Biomed Res Int. 2018;2018:2617439.
   PubMed     Text format     Abstract available
   
   

   
   BJU Int

6. QU LG, Lawrentschuk N
   Bladder cancer surveillance in patients with spinal cord injuries.
   BJU Int. 2018 Oct 8. doi: 10.1111/bju.14582.
   PubMed     Text format     Abstract available
   
   

   
   BMC Med Genomics

7. ANSARI AA, Park I, Kim I, Park S, et al
   Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.
   BMC Med Genomics. 2018;11:88.
   PubMed     Text format     Abstract available
   
   

   
   BMJ Case Rep

8. CERIER E, Beal EW, Dillhoff ME
   Inflammatory myofibroblastic tumour: an unusual presentation including small bowel obstruction and palpable abdominal mass.
   BMJ Case Rep. 2018;2018.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

9. GARG T, Young AJ, O'Keeffe-Rosetti M, McMullen CK, et al
   Association between treatment of superficial bladder cancer and 10-year mortality in older adults with multiple chronic conditions.
   Cancer. 2018 Oct 5. doi: 10.1002/cncr.31705.
   PubMed     Text format     Abstract available
   
   
10. WOLDU SL, Sanli O, Clinton TN, Lotan Y, et al
    Validating the predictors of outcomes after radical cystectomy for bladder cancer.
    Cancer. 2018 Oct 6. doi: 10.1002/cncr.31799.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Manag Res

11. YAN H, Ying Y, Xie H, Li J, et al
    Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis.
    Cancer Manag Res. 2018;10:3781-3791.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Med

12. LIN HY, Ye H, Kernen KM, Hafron JM, et al
    National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging.
    Cancer Med. 2018 Oct 10. doi: 10.1002/cam4.1684.
    PubMed     Text format     Abstract available
    
    

    
    Cell Death Dis

13. LIU Z, Xie D, Zhang H
    Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis.
    Cell Death Dis. 2018;9:1042.
    PubMed     Text format     Abstract available
    
    

    
    Clin Genitourin Cancer

14. NECCHI A, Pond GR, Moschini M, Plimack ER, et al
    Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2018 Sep 13. pii: S1558-7673(18)30482.
    PubMed     Text format     Abstract available
    
    

    
    Clin Nucl Med

15. PARIHAR AS, Vadi SK, Mittal BR, Kumar R, et al
    68Ga-PSMA-HBED-CC-Avid Synchronous Urinary Bladder Paraganglioma in a Patient With Metastatic Prostate Carcinoma.
    Clin Nucl Med. 2018;43:e329-e330.
    PubMed     Text format     Abstract available
    
    

    
    Clin Transl Oncol

16. RUBIO C, Munera-Maravilla E, Lodewijk I, Suarez-Cabrera C, et al
    Macrophage polarization as a novel weapon in conditioning tumor microenvironment for bladder cancer: can we turn demons into gods?
    Clin Transl Oncol. 2018 Oct 5. pii: 10.1007/s12094-018-1952.
    PubMed     Text format     Abstract available
    
    

    
    Environ Mol Mutagen

17. ESPINOZA F, Cecchini L, Morote J, Marcos R, et al
    Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosis.
    Environ Mol Mutagen. 2018 Oct 4. doi: 10.1002/em.22252.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Pharmacol

18. CHENG CL, Chao WT, Li YH, Ou YC, et al
    Escin induces apoptosis in human bladder cancer cells: An in vitro and in vivo study.
    Eur J Pharmacol. 2018 Oct 1. pii: S0014-2999(18)30575.
    PubMed     Text format     Abstract available
    
    

    
    Eur Urol

19. GRIFFIN JL
    Devil in the Detail: Intratumour Heterogeneity and Personalised Medicine for Bladder Cancer.
    Eur Urol. 2018 Oct 3. pii: S0302-2838(18)30724.
    PubMed     Text format    
    
    
20. MOSCHINI M, Zaffuto E, Karakiewicz PI, Andrea DD, et al
    External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Eur Urol. 2018 Oct 4. pii: S0302-2838(18)30722.
    PubMed     Text format     Abstract available
    
    
21. PIETZAK EJ, Zabor EC, Bagrodia A, Armenia J, et al
    Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
    Eur Urol. 2018 Oct 2. pii: S0302-2838(18)30652.
    PubMed     Text format     Abstract available
    
    
22. WITJES JA
    Radiofrequency-induced Thermochemotherapy for Recurrent Non-muscle-invasive Bladder Cancer: A New Treatment for an Unmet Need?
    Eur Urol. 2018 Oct 4. pii: S0302-2838(18)30727.
    PubMed     Text format    
    
    

    
    Eur Urol Focus

23. WU Y, Jiang G, Zhang N, Liu S, et al
    HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Eur Urol Focus. 2018 Oct 8. pii: S2405-4569(18)30289.
    PubMed     Text format     Abstract available
    
    

    
    Exp Oncol

24. HARPER P, Hald O, Lwaleed BA, Kyyaly A, et al
    The impact of morphine treatment on bladder cancer cell proliferation and apoptosis: in vitro studies.
    Exp Oncol. 2018;40:190-193.
    PubMed     Text format     Abstract available
    
    

    
    Front Surg

25. NGUYEN TT, Huillard O, Dabi Y, Anract J, et al
    Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience.
    Front Surg. 2018;5:58.
    PubMed     Text format     Abstract available
    
    

    
    In Vivo

26. YASUDA T, Miyata Y, Nakamura Y, Sagara Y, et al
    High Consumption of Green Tea Suppresses Urinary Tract Recurrence of Urothelial Cancer via Down-regulation of Human Antigen-R Expression in Never Smokers.
    In Vivo. 2018;32:721-729.
    PubMed     Text format     Abstract available
    
    
27. LIAW CC, Chuang CK, Chang YH, Chang JW, et al
    Under-stage and Overlook of Peritoneal Spread from Bladder Urothelial Carcinoma.
    In Vivo. 2018;32:905-910.
    PubMed     Text format     Abstract available
    
    

    
    Indian J Surg Oncol

28. AGARWALA V, Ramaswamy A, Dsouza S, Pande N, et al
    Resection of Isolated Port Site Metastasis in Gall Bladder Cancers-Careful Selection and Perioperative Systemic Therapy May Improve Outcomes.
    Indian J Surg Oncol. 2018;9:427-431.
    PubMed     Text format     Abstract available
    
    

    
    Int J Hyperthermia

29. SCHOONEVELDT G, Kok HP, Bakker A, Geijsen ED, et al
    The effect of air pockets in the urinary bladder on the temperature distribution during loco-regional hyperthermia treatment of bladder cancer patients.
    Int J Hyperthermia. 2018 Oct 10:1-9. doi: 10.1080/02656736.2018.1506890.
    PubMed     Text format     Abstract available
    
    

    
    Int Neurourol J

30. PARK RJ, Hong YJ, Wu Y, Kim PM, et al
    Exosomes as a Communication Tool Between the Lymphatic System and Bladder Cancer.
    Int Neurourol J. 2018;22:220-224.
    PubMed     Text format    
    
    

    
    J Cancer

31. ZHANG L, Wang Y, Qin Z, Li R, et al
    TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status.
    J Cancer. 2018;9:3522-3531.
    PubMed     Text format     Abstract available
    
    

    
    J Cell Biochem

32. ZHANG S, Chang YY, Gong YW, Gao YJ, et al
    Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells.
    J Cell Biochem. 2018 Oct 10. doi: 10.1002/jcb.27922.
    PubMed     Text format     Abstract available
    
    

    
    J Med Imaging Radiat Oncol

33. GOGNA NK, Duchesne G, O'Brien P, Spry N, et al
    Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma.
    J Med Imaging Radiat Oncol. 2018;62:668-670.
    PubMed     Text format    
    
    

    
    J Prev Med Public Health

34. SEO M, Langabeer Ii JR
    Demographic and Survivorship Disparities in Non-muscle-invasive Bladder Cancer in the United States.
    J Prev Med Public Health. 2018;51:242-247.
    PubMed     Text format     Abstract available
    
    

    
    J Proteomics

35. AZEVEDO R, Silva AMN, Reis CA, Santos LL, et al
    In silico approaches for unveiling novel glycobiomarkers in cancer.
    J Proteomics. 2018;171:95-106.
    PubMed     Text format     Abstract available
    
    

    
    J Robot Surg

36. BAILEY GC, Frank I, Tollefson MK, Gettman MT, et al
    Perioperative outcomes of robot-assisted laparoscopic partial cystectomy.
    J Robot Surg. 2018;12:223-228.
    PubMed     Text format     Abstract available
    
    

    
    Mol Cancer

37. ZHENG R, Du M, Wang X, Xu W, et al
    Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
    Mol Cancer. 2018;17:143.
    PubMed     Text format     Abstract available
    
    
38. XIE F, Li Y, Wang M, Huang C, et al
    Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis.
    Mol Cancer. 2018;17:144.
    PubMed     Text format     Abstract available
    
    

    
    Mol Nutr Food Res

39. HE C, Huang L, Lei P, Liu X, et al
    Sulforaphane Normalizes Intestinal Flora and Enhances Gut Barrier in Mice with BBN-Induced Bladder Cancer.
    Mol Nutr Food Res. 2018 Oct 10:e1800427. doi: 10.1002/mnfr.201800427.
    PubMed     Text format     Abstract available
    
    

    
    Molecules

40. WU P, Meng X, Zheng H, Zeng Q, et al
    Kaempferol Attenuates ROS-Induced Hemolysis and the Molecular Mechanism of Its Induction of Apoptosis on Bladder Cancer.
    Molecules. 2018;23.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

41. HSIEH HY, Jou YC, Tung CL, Tsai YS, et al
    Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Oncogene. 2018;37:673-686.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

42. MORGAN MJ, Fitzwalter BE, Owens CR, Powers RK, et al
    Metastatic cells are preferentially vulnerable to lysosomal inhibition.
    Proc Natl Acad Sci U S A. 2018;115:E8479-E8488.
    PubMed     Text format     Abstract available
    
    

    
    Res Rep Urol

43. MORIZAWA Y, Miyake M, Shimada K, Hori S, et al
    Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy.
    Res Rep Urol. 2018;10:103-111.
    PubMed     Text format     Abstract available
    
    

    
    Sci Rep

44. MAJ M, Kokocha A, Bajek A, Drewa T, et al
    The interplay between adipose-derived stem cells and bladder cancer cells.
    Sci Rep. 2018;8:15118.
    PubMed     Text format     Abstract available
    
    
45. NOGUERA-ORTEGA E, Rabanal RM, Gomez-Mora E, Cabrera C, et al
    Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice.
    Sci Rep. 2018;8:15102.
    PubMed     Text format     Abstract available
    
    

    
    Urologe A

46. LOIDL W, Luger F
    [Immunotherapy for locally advanced and metastasized bladder cancer].
    Urologe A. 2018 Oct 9. pii: 10.1007/s00120-018-0785.
    PubMed     Text format     Abstract available
    
    

    
    World J Surg Oncol

47. SHEN PL, Lin ME, Hong YK, He XJ, et al
    Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies.
    World J Surg Oncol. 2018;16:197.
    PubMed     Text format     Abstract available
    
    

    
    World J Urol

48. BACHOUR K, Faiena I, Salmasi A, Lenis AT, et al
    Trends in urinary diversion after radical cystectomy for urothelial carcinoma.
    World J Urol. 2018;36:409-416.
    PubMed     Text format     Abstract available
    
    
49. CLIFFORD TG, Katebian B, Van Horn CM, Bazargani ST, et al
    Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients.
    World J Urol. 2018 Jan 25. pii: 10.1007/s00345-018-2181.
    PubMed     Text format     Abstract available
    
    
50. NAHAR B, Koru-Sengul T, Miao F, Prakash NS, et al
    Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy.
    World J Urol. 2018;36:393-399.
    PubMed     Text format     Abstract available
    
    
51. BAZARGANI ST, Ghodoussipour S, Tse B, Miranda G, et al
    The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol.
    World J Urol. 2018;36:401-407.
    PubMed     Text format     Abstract available
    
    

    
    Zhonghua Zhong Liu Za Zhi

52. HE YT, Li DJ, Liang D, Zheng RS, et al
    [Incidence and mortality of bladder cancer in China, 2014].
    Zhonghua Zhong Liu Za Zhi. 2018;40:647-652.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: